Executive Summary

Amazon Web Services (AWS) is recognized with the 2025 Excellence in R&D award in the cloud services category for its continued focus on driving innovation in cloud technology from research to scaled, enterprise-ready solutions. By its continued focus on core infrastructure, distributed systems, security, and cloud-native solutions, AWS has been able to leverage its research strengths into robust, high-performance, and scalable cloud solutions for various sectors.

Notably, AWS's R&D approach is centered on innovation, resilience, and security, with a focus on strong governance and improvement in its cloud offerings. Collectively, these successes reflect AWS’s persistence in providing strong, differentiated, and business-driven cloud solutions through excellence in R&D in 2025.

Executive Summary

BCC Research has announced its 2025 Excellence in Product Launch Award to Vertex Pharmaceuticals Incorporated. Vertex demonstrates its expertise in pharmaceutical commercialization through its recent successful launches, notably Casgevy (gene editing), Journavx (non-opioid pain management), and Alyftrek (next-generation cystic fibrosis treatment). Vertex Pharmaceuticals has shifted its identity from a cystic fibrosis-centric firm to a diverse biotech giant, recognized by the Excellence in Product Launch award. By prioritizing high-stakes R&D and aggressive portfolio diversification, Vertex Pharmaceuticals achieved a landmark "triple launch" year in 2025. This milestone saw the company successfully commercialize three transformative treatments spanning diverse therapeutic categories, including gene editing, respiratory diseases, and non-opioid pain relief.

Executive Summary

Lilly USA LLC. is nominated for the 2025 Excellence in Market Growth Award by BCC Research for exceptional market growth. The company became the first healthcare firm to reach a market capitalization of $1 trillion in 2025. It also achieved major expansion in the diabetes market and made a significant contribution with its cutting-edge metabolic portfolio. In 2025, the company recorded an impressive 94.2% year-over-year revenue growth during the first nine months for its primary product, Mounjaro, which strengthens its product portfolio and reflects its ability to scale innovative treatment solutions, improve patient access, and strengthen its competitive positioning in the diabetes care landscape.

The award evaluation is based on a structured, multi-parameter framework designed to assess market growth execution. BCC Research evaluated prominent companies working in the diabetes therapeutics domain using a combination of various indicators. These indicators, including manufacturing capacity, supply chain resilience, geographic expansion, product performance, and year-on-year revenue contribution of the product (diabetes), were applied to leading companies to assess their performance. Lilly demonstrated outstanding market growth within the diabetes therapeutics segment, driven by strong commercial execution and strategic expansion across key geographies. The company expanded patient access by launching its flagship diabetes therapy in key markets such as India, making its strategic shift to South Asia, and strengthening its distribution network through local partnerships.

Executive Summary

Amkor Technology is recognized with the 2025 Excellence in Market Growth Award in the Outsourced Semiconductor Assembly and Test (OSAT) domain by BCC Research. This award reflects, company's strategic market position and its geographic expansion, together with its technological development in a vital and rapidly evolving sector. The company offers a broad advanced packaging portfolio, such as 2.5D, high-density fan-out, and system-in-package (SiP), that catered to a wider customer base and contributed to the company’s market growth. Also, the company has deep integration with key foundries and fabless players, along with a geographically diversified manufacturing footprint spanning the U.S., South Korea, Vietnam, Portugal, and other strategic locations.

The award evaluation is based on a structured, multi-parameter framework designed to assess market growth execution. BCC Research evaluated prominent companies working in the OSAT domain using a combination of various indicators. These indicators, including capacity and revenue expansion trends, geographic diversification, depth of advanced packaging capabilities, and strength of customer ecosystems, were applied to leading OSAT companies to assess their performance. Amkor reported approximately 31% sequential revenue growth in Q3 2025, driven largely by increased demand for advanced packaging solutions linked to artificial intelligence (AI) and high-performance computing (HPC) programs.

Executive Summary

Bloom Energy is being presented with the 2025 Excellence in Sustainable Innovation Award for successfully transforming advanced solid-oxide technology research into commercially scalable, low-emission fuel cell systems. Celebrating its 25th anniversary in 2026, the company successfully transitioned its initial fuel cell system research to the early commercialization stage deploying small scale systems at commercial and industrial locations. Now, the company offers a variety of power generation and hydrogen solutions deployable across industries globally, including increasingly larger solutions for commercial and industrial, utility and data center customers.

Bloom has been at the forefront of energy innovation for more than two decades, providing alternatives to centralized energy. It designs, manufactures, distributes, and operates the Bloom Energy Server to provide resilient, distributed power for critical operations. It has driven sustainability innovation and excellence through deployments of advanced microgrids reducing the need for backup generation, hydrogen systems capable of producing zero carbon power, and combined heat and power solutions delivering both high efficiency power generation and useful heat to support building operations. It’s ability to deploy large scale non-combustion power generation solutions quickly to support the rapid growth of digital infrastructure set it apart from the competition and help enhance the sustainability and competitiveness of both industry and communities alike.

Executive Summary

Schneider Electric stands out in Operational AI excellence in the energy sector by embedding artificial intelligence at the core of its sustainability and business strategy. Through its EcoStruxure architecture and platform, Schneider has industrialized AI across predictive maintenance, energy optimization, process efficiency, and asset lifecycle management, delivering measurable and repeatable sustainability outcomes at global scale.

Real-world deployments demonstrate this impact, where Schneider’s AI-powered EcoStruxure Asset Advisor and EcoCare services use predictive analytics and continuous monitoring to extend asset life, reduce unplanned downtime, and cut maintenance-related emissions across grids, substations, and energy-intensive industrial assets. In industrial applications, EcoStruxure Industrial Advisor – Predictive Energy has enabled customers to reduce energy consumption by up to 10% and associated carbon emissions by as much as 40%, with ROI often achieved in under six months.

Beyond operations, Schneider integrates sustainability across the full product lifecycle with digital twins, circular economy design, refurbishment, and AI-driven energy efficiency aligning with its corporate goal of helping customers save and avoid 800 million tonnes of CO₂ emissions by 2030. Critically, these AI innovations are commercially viable, scalable, and profitable, underpinning long-term growth.

Executive Summary

Valero stands out as a strategic market visionary in the sustainable energy industry by maintaining its leadership in the biofuel industry. The company exemplifies its dominant position in strategic execution leadership through its business expansion in the biofuel industry, strong financial position, and disciplined supply chain operations amid various challenges like limited feedstock supply, high cost, intense competition, and trade policies. It has achieved record refining throughput of 3.2 million barrels per day at its 15 refineries spanning across the U.S., the U.K., and Canada. It has also successfully maintained safety standards while advancing low-carbon fuels like sustainable aviation fuel (SAF) and renewable diesel.

The award evaluation is based on a structured, multi-parameter framework designed to assess market growth execution. BCC Research evaluated various companies working in the biofuel domain using a combination of various indicators. These indicators, including capacity expansion trends, execution efficiency of capital expenditure, sustainability throughout the operations, and key milestones achieved, were applied to leading biofuel companies to assess their performance. Valero reported an exceptional 95% plant utilization rate in Q4 2025, driven largely by strong throughput records and profitability margins in biofuel business segments.

Executive Summary

Xylem stands out in the Sustainable Innovation Leadership award in the advanced material sector, with a focus on the water treatment and management market. It shows exceptional performance in the sustainability segment across various fronts, including strong innovation economics, scalable operating models, and plausible climate leadership. It sets the benchmark for other peers in the water industry on how sustainable innovation can deliver environmental, social, and economic value on a global scale.

The environmental impact justified by the company’s strategic initiative towards establishing 1.5°C-aligned Science-Based Targets covering Scope 1, 2, and 3 emissions, validated by the SBTi in 2024, with a commitment to net-zero by 2050. The company’s R&D investment of more than $200 million annually, along with digital integration and strategic acquisitions such as Idrica, is strengthening its Xylem Vue platform, further positioning the organization at the forefront of next-generation water technologies. Sustainability-based financing decisions directly impact the environmental performance of capital and shape the financial strategy. The company's sustainability leadership is further supported by science-based climate commitments, policy engagement, and partnerships that impact standards across the water sector.

Executive Summary

AUO Corp. is nominated for the 2025 Excellence in New Product Innovation Award in the display components category by the BCC Research. This award highlights the company's strategic initiative in line with the integration of next-generation display technologies, particularly in the MicroLED and organic light-emitting diode (OLED) technology, advancing them from prototype validation to market-ready demonstrations. The company offers a broad range of transparent display solutions, including MicroLED transparent display panels, modules, and digital cockpit solutions that deliver high transparency and ultra-bright brightness of over 1,000 nits and more. Also, the company offers various integrated transparent display solutions under their SeeThrµ series, including transparent displays with over 60% transparency, suitable for retail, commercial, and automotive applications.

The award assessment was based on the structured research methodology and process combining market scanning, peer benchmarking, and scoring-based validation. Prominent factors such as cross-industry applicability, depth of display technology integration, and diversification in end-use applications were analyzed across the display solutions and component manufacturers. In line with this, the AUO Corp. showcased its various novel transparent display solutions, ranging from display panels to modules. One such example is AUO Corp.'s 17.3-inch dual-sided transparent MicroLED display showcased in 2025. The company, with its innovative display technology, provided a dual interactive transparent solution to overcome the issues of space and transparency.

Executive Summary

BASF has been nominated for the Excellence in Product Launch Award for demonstrating strong commercialization discipline by systematically converting R&D outputs into polymer and advanced-material solutions aligned with trends such as electrification, lightweighting, and circular-economy plastics. In the first 9 months, ending September 2025, BASF invested around $1.7 billion in research and development, leading to the launch of various new products. Furthermore, BASF filed 1,159 new patents, roughly 45% of which were focused on sustainability. BASF's integrated Verbund production model enables rapid industrialization of new grades by leveraging shared intermediates, utilities, and infrastructure, reducing scale-up risk compared with stand-alone specialty producers. Rather than pursuing high-volume launches, BASF focuses on targeted, application-specific introductions with OEMs, resulting in longer product lifecycles and stronger margin retention.

The award nomination is supported by a structured evaluation framework emphasizing market understanding and commercialization, strategies, execution discipline, and innovation scalability. BASF demonstrates measurable success through sustained sales contributions from recently introduced products, strong patent activity in sustainable and high-performance materials, and co-development partnerships with OEMs and converters that accelerate qualification and adoption. Independent benchmarking highlights BASF's ability to couple scientific innovation with industrial readiness, supported by cross-functional collaboration among research, application engineering, and production teams.

Executive Summary

Daikin Industries Ltd. is nominated by BCC Research for the 2025 Excellence in Sustainable Innovation Award in recognition of its notable contributions toward achieving carbon-neutral targets across its business verticals and its continued commitment to carbon reduction and sustainability-driven innovation. For instance, as of June 2025, three manufacturing plants of Daikin Industries, including Daikin Air-Conditioning (Shanghai) Co., Ltd., the Rinkai Factory at the Sakai Plant, and Daikin Rexxam Electronics Co., Ltd., had reached the goal of net-zero GHG (Greenhouse Gas) emissions, well ahead of the corporate schedule (which is planned by 2030). Also, the company has a strong focus on sustainable innovation, such as energy-efficient technologies, and shifting to low-GWP refrigerants.

The methodology included market scanning to identify companies from the refrigeration and cooling domain. Upon identification of the companies, the analyst performed a competitive benchmarking exercise to assess peer performance across diverse parameters, such as energy efficiency, transition to green refrigeration, and priority for innovative sustainable practices in the refrigeration equipment industry. Based on this assessment, Daikin Industries was selected for further evaluation. The company was then evaluated based on core performance metrics, like environmental impact, business viability, innovation quality, circular economy integration, and ESG governance, including climate risk management at the board level and sustainability-relevant factors.

Executive Summary

Gilead Sciences Inc. is nominated for the 2025 Excellence in Innovation Barrier Breaker Award by BCC Research for fundamentally reshaping the HIV prevention paradigm. Gilead Sciences is a biopharmaceutical company active in HIV care, advancing long-acting therapies to address unmet needs in treatment as well as prevention. In June 2025, the company introduced a first-in-class capsid inhibitor, Yeztugo (lenacapavir), with twice-yearly dosing. This innovative drug aided in breaking down barriers that had long defined traditional HIV prevention methods and helped overcome challenges related to therapy adherence and stigma, thereby making prevention more accessible for vulnerable and high-risk populations at a wider scale.

The award assessment was based on the structured research methodology and process combining market scanning, peer benchmarking, and scoring-based validation. Prominent factors such as first-in-class scientific novelty, dosing frequency disruption Index, and patient and community preference validation were analyzed across the HIV prevention drug companies. In line with this, Gilead Sciences Inc. demonstrated that innovative drugs can be delivered to the world’s most vulnerable population at the same time they are introduced in the developed part of the world. For instance, Yeztugo operates outside all currently approved antiviral classes, resetting the scientific benchmark, altering competitive strategy, and redefining the future standard of care in HIV prevention.

Executive Summary

BCC Research has nominated Medtronic for the 2025 Excellence in Market Strategy award for its market transition strategy, which aimed to reshape the standard of care in the cardiovascular therapeutic area, such as cardiac rhythm management. The company refocused its efforts from growing competition within traditional transvenous implantable cardioverter defibrillator (ICD) systems to increasing use of extravascular and physiological pacing platforms as the next phase of cardiac rhythm management. It is an important strategic move as it positioned Medtronic to shape the future direction of cardiac rhythm management, guiding the market toward minimally invasive, and strengthening its long-term competitive position. For instance, at the European Society of Cardiology (ESC) in September 2025, Medtronic used real-world information along with current clinical data outcomes to strategically strengthen an extensive move towards physiological pacing and extravascular defibrillation as the next standard of care.

The approach of the award assessment is based on a structured research methodology across the cardiovascular device landscape, starting with a logical market scanning of regulatory, clinical, and commercial developments, followed by the shortlisting of prominent players. Extensive analysis has been conducted for the selected company to portray how the company aligned clinical validation, regulatory sequencing, and geographic rollout to support a defined cardiovascular market strategy. For instance, in 2025, the company advanced its market strategy by leveraging regulatory clearances to expand the commercial deployment of Micra AV2 and Micra VR2 leadless pacemakers, supporting a careful shift away from conventional transvenous pacing systems.

Executive Summary

Siemens AG has been nominated for the 2025 Excellence in Digital Transformation Award in industrial automation based on strong evidence of enterprise-wide digital leadership that integrates strategy, technology, and operational execution. Its FY-2025 Siemens highlights record performance linked to software-and-services-driven growth model and the CEO-led ONE Tech operating framework, which unifies automation, software, and data capabilities across business units. This governance and operating structure have enabled Siemens to embed digitalization systematically into core processes, rather than treating it as a peripheral innovation initiative.

The award nomination is framed around a structured, evidence-based evaluation model that integrates market scanning, shortlisting, in-depth organizational analysis, and a weighted scoring framework to assess enterprise-wide digital transformation maturity. BCC Research emphasized transformation scope, technology integration, business results, change leadership, and sustainability impacts. The framework is supported by both quantitative KPIs and qualitative governance and cultural indicators, validated through peer benchmarking, independent third-party recognition, and documented customer outcomes, thereby ensuring that Siemens’ nomination is based on verifiable performance.

Executive Summary

BCC Research has nominated Stryker for the 2025 Excellence in Technology Integration award for its ability to integrate multiple orthopedic surgical robotic technologies through a single, advanced robotic architecture. In March 2025, Stryker launched MAKO 4, its fourth-generation single system, which pushed the boundaries of orthopedic robot technology. It combines next-generation haptic feedback and 3D CT-based planning, which allows surgeons to plan the implant size and precise positioning before the surgery. The newly launched MAKO Shoulder includes Tornier implants, Blueprint planning software, and Mako Smart Robotics, which offers haptically guided preparation for Tornier to perform a reversed glenoid. The integration of high-fidelity spatial mapping enables the system to dynamically scale its capabilities. This allows surgical teams to transition effortlessly from large-joint procedures to the high-precision requirements of shoulder and spine surgeries.

The award selection criteria are based on a systematic, multi-parameter approach to technology integration evaluation. The assessment focused on different technology integration-related parameters, such as surgical accuracy, workflow efficiency, platform evolution, and technology-integrated clinical scalability. By the end of December 2025, Stryker had supported over 2 million robotic procedures across Mako Total Knee, Mako Total Hip, and Mako Partial Knee, and over 1 million robotic Mako Total Knee procedures in 45 countries worldwide, demonstrating Internal Review only, unlicensed copy technology-integrated clinical scalability and solidifying robotic-assisted joint repair as a standard of care.

Executive Summary

PPG Industries Inc. has been nominated for the New Product Innovation award in the coating sector, with a focus on the non-methanol hard coating, two-coat powder systems, and sustainable coatings technologies. It shows exceptional performance in the product innovation segment across various fronts, including scientific research, patent applications, marine coatings, and low-VOC waterborne coatings. It sets the benchmark for other peers in the coating industry on how product innovation can build new business opportunities in the developing world.

The award assessment was based on the structured research methodology and process combining market scanning, peer benchmarking, and scoring-based validation. BCC Research evaluated various companies working in the coating domain using a combination of various indicators such as technological novelty, patent position, application efficiency growth in end use, AI/ML integration, and bio-based content were used to evaluate companies. The analysis was further based on the government publication and availability of public disclosures, sustainability reports of key players, and deployment data of coatings. PPG Industries Inc.’s long-term strategy focused on sustainable raw materials, energy-efficient technologies, and consumption of post-industrial recycled plastic along with constant focus on emerging coating technologies has contributed to the company’s current position as a prominent player in coating innovation compared to traditional players.

Executive Summary

Abridge AI, Inc. is nominated for the 2025 Excellence in Generative AI Applications Award by BCC Research for reshaping clinical documentation workflows through advanced generative AI technology. Abridge AI, Inc. is a healthcare technology company that creates generative AI-powered clinical documentation platforms to help clinicians deal with growing administrative burdens and inefficiencies associated with manual medical documentation. In 2025, the company expanded its platform deployment across multiple healthcare systems. For instance, in February 2025, Inova Health System deployed the Abridge platform across several specialties. This allowed over 1,000 Inova clinicians to provide better service to patients.

The award assessment was based on the structured research methodology and process combining market scanning, peer benchmarking, and scoring-based validation. Prominent factors such as clinical workflow impact, strategic partnerships, and integration with the EHR ecosystem were analyzed across the companies providing generative AI solutions for clinical documentation and ambient medical scribing. In line with this, Abridge AI, Inc. demonstrated high financial momentum to scale its AI platform. For instance, the company secured a funding round in February 2025 of a $250 million Series D investment led by Elad Gil and IVP, with participation from investors including Bessemer Venture Partners, CapitalG, CVS Health Ventures, and NVentures.

Executive Summary

Jazz Pharmaceuticals Inc. is nominated for the 2025 Excellence in Innovation Barrier Breaker Award by BCC Research for fundamentally transforming pediatric oncology therapy. The company demonstrated innovation in pediatric oncology with Modeyso, the first targeted systemic therapy for Recurrent H3 K27M-mutant Diffuse Midline Glioma, launched in August 2025. This innovative drug breaks barriers by addressing brain tumors with very poor prognosis and historically limited treatment options, where patients mainly relied on radiation therapy and had no effective chemotherapy, targeted therapy, or immunotherapy available.

The award assessment was based on a structured research method and process that combined market scanning, peer benchmarking, and scoring-based validation. Most significant factors, such as therapeutic breakthrough impact, the severity of unmet medical needs, and the pediatric suitability index, were analyzed across pediatric oncology companies. In this regard, Jazz Pharmaceuticals has developed the first and only approved treatment for diffuse midline glioma with H3K27 M mutation, an ultra-rare and highly aggressive brain tumor caused by a mutation that disrupts epigenetic regulation and drives tumor growth.

Executive Summary

Lam Research is nominated for the 2025 Excellence in Product Launch award in the semiconductor fabrication equipment domain by BCC Research. The award recognized the company's performance in the product launch process, including the degree of innovation in newly introduced products and the extent to which these products achieved confirmed customer adoption. For instance, in February 2025, the company introduced an etching system named Akara and announced that it was selected as the tool of production for multiple applications related to advanced planar dynamic random-access memory (DRAM) and foundry gate-all-around (GAA), a confirmation that showed the achievement of market adoption within the launch process itself rather than after it.

The award assessment was based on the structured research methodology and process combining market scanning, peer benchmarking, and scoring-based validation. Prominent factors such as confirmed customer adoption during the product launch, advanced node alignment for next-generation manufacturing across GAA, DRAM, and 200+ layer NAND transitions, and the presence of customer endorsements during the product's official launch were analyzed across semiconductor fabrication equipment manufacturers. In line with this, in February 2025, Lam Research introduced the ALTUS Halo molybdenum atomic layer deposition (ALD) platform, which entered high-volume manufacturing (HVM) at 3D NAND manufacturers in South Korea and Singapore and at advanced logic fabs.

Executive Summary

Nel ASA exemplifies excellence in next-generation technology within the green hydrogen electrolyzer industry. The company sustained its leadership in deploying next-gen technologies despite persistent market volatility. This stems from its intensive focus on technology-based R&D, capital optimization, and disciplined supply chain operations amid various challenges, including high costs, intense competition, shifts in government policies, and limited offtake agreements.

The award evaluation is based on a structured, multi-parameter framework designed to assess market growth execution. BCC Research evaluated prominent companies working in the green hydrogen domain using a combination of various indicators. These indicators, including capacity expansion trends, execution efficiency of capital expenditures, sustainability throughout operations, and the value of confirmed orders, were applied to leading green hydrogen companies to assess their performance. In line with this, Nel ASA launched a pressurized alkaline electrolyzer at its Heroya facility dedicated to electrolyzer manufacturing, aimed at reducing CapEx by 40%-60%, and levelized cost of hydrogen (LCOH) by 30%-40%.

Executive Summary

Siemens is nominated for the 2025 Excellence in Operational AI Award by BCC Research for advancing the application of AI in industrial operations. During 2025, the company continued its expansion of operational AI solutions for the manufacturing and industrial automation industry with its Industrial AI portfolio, its digital twin solutions, and its Industrial Copilot solutions as part of the Siemens Xcelerator ecosystem. Its use of AI-enabled digital twins and edge-based analytics helped factories simulate processes, detect inefficiencies in the factory operations, and improve the reliability of equipment.

The award assessment was based on the structured research methodology and process combining market scanning, peer benchmarking, and scoring-based validation across companies implementing operational AI in industrial settings. Evaluation parameters included operational impact, system reliability, integration with existing operational systems, workforce enablement, and financial return from AI-driven automation. In accordance with this, Siemens recorded notable results in 2025 with the use of Industrial Copilot tools that aided engineering and production staff, AI-based predictive maintenance solutions that were connected to factory equipment, and flexible digital manufacturing solutions that were used in various industrial plants.

Executive Summary

Toray stands out in the market strategy award in the advanced material sector, with a key focus on carbon fibers. It demonstrates exceptional financial stability for the targeted segment, including broad product diversification and strong sustainability and future readiness. It sets the benchmark for other peers in the carbon fiber industry on how sustainable innovation can deliver environmental, social, and economic value on a global scale. The company operates an extensive global manufacturing and R&D network across Asia, North America, and Europe, spanning key industries such as aerospace, automotive, energy, electronics, and water treatment. In the carbon fiber market, Toray maintained a leading position with strong vertically integrated operations. It enables consistent product quality, secure supply, and strong collaboration across aviation, mobility, and renewable energy infrastructure. The company also prioritizes R&D investment with strong governance and sustainability practices.

The award assessment was based on a structured research methodology and process that combined market scanning, peer benchmarking, and scoring-based validation. The company's focus on strengthening production capacity, addressing product diversification needs, and expanding into multiple geographies supports its efforts to gain a strong foothold in market strategy. For instance, in 2025, Toray announced plans to increase the annual capacity of regular tow carbon fiber production by 20% to 35,000 metric tons to meet demand for pressure vessel applications in South Korea and the U.S.

Executive Summary

Amcor plc stands out in the Excellence in AI Research & Core Innovation Award in the packaging sector, driven by its advanced application of AI to enhance recyclability, sustainability, manufacturing efficiency, and product design innovation. The company demonstrates a robust commitment to AI-led research and core innovation across both flexible and rigid packaging, accelerating design processes and aligning solutions closely with evolving consumer and industry demands.

Amcor plc is actively leveraging AI-driven research and innovation to develop more sustainable plastic packaging solutions for the food, beverage, healthcare, and personal care sectors. With increasing pressure to meet ESG standards, end users are demanding eco-friendly and recyclable packaging, and Amcor’s AI-led approach enables it to effectively address these evolving requirements. Its continued investment in AI innovation sets a strong benchmark for peers in the packaging industry and opens new avenues for growth, particularly in emerging markets.

The award assessment was based on the structured research methodology and process combining market scanning, peer benchmarking, and scoring-based validation. Factors such as operational efficiency & productivity, quality control & defect detection, sustainability & waste reduction, design & prototyping, and supply chain & demand forecasting were used to evaluate companies. The analysis was further based on the government publication and availability of public disclosures, sustainability reports of key players, and deployment data of packaging

Executive Summary

Amgen Inc. is nominated for the 2025 Excellence in Innovation Barrier Breaker Award by BCC Research for fundamentally transforming the treatment landscape of small cell lung cancer (SCLC). The company demonstrated significant innovation with IMDELLTRA (tarlatamab-dlle), the first and only DLL-3 targeted bispecific T-cell engager (BiTE) therapy for extensive-stage SCLC (ES-SCLC), which received FDA approval in May 2024 and full approval for commercialization in the U.S. market in November 2025. This breakthrough therapy marks a significant clinical advancement, ending a 30-year stagnation in treating SCLC, a disease historically linked to poor prognosis. By targeting the DLL-3 protein, which is found in approximately 85-94% of SCLC tumors, Amgen has developed a high-precision treatment option that transcends the limitations of traditional chemotherapy. This innovation addresses a crucial need in oncology, providing a more personalized and effective solution for patients who have previously had few viable treatment alternatives.

The award assessment was based on the structured research methodology and process combining market scanning, peer benchmarking, and scoring-based validation. Prominent factors such as Therapeutic Barrier Significance, Solution Innovation, and Commercial Impact. Amgen was recognized for its innovative approach to BiTE therapy delivery, transitioning from extended inpatient care to more efficient outpatient procedures. This development marks a significant shift in global oncology treatment practices, establishing a new standard for improved accessibility and operational effectiveness.

Executive Summary

Asahi Kasei stands out in the Next-Generation Technology Award in the advanced material sector, with a key focus on ion-exchange membranes. It demonstrates exceptional technology leadership for the targeted segment, including strong financial impact, positive commercial deployment, strong sustainability and a strategic geographical positioning. It sets the benchmark for peers in the ion-exchange membranes industry on how technology innovation can go hand in hand with sustainability, delivering environmental, social, and economic value on a global scale. In this segment, the company is largely focusing on Europe and some parts of the Asia-Pacific. In the ion-exchange membranes segment, Asahi Kasei maintained a leading position with strong membrane technology and its successful system-level integration.

The award assessment was based on a structured research methodology and process that combined market scanning, peer benchmarking, and scoring-based validation. The company's focus on strengthening production capacity, addressing product diversification needs, and expanding into multiple geographies supports its efforts to gain a strong foothold in market strategy. For instance, in 2025, Asahi Kasei announced plans to expand capacity to manufacture system components for clean hydrogen. The company planned to supply its Aqualyzer-C3 containerized 1 MW-class alkaline-water electrolyzer to the Central Finland Mobility Foundation (Cefmof).

Executive Summary

AT&T is nominated for the 2025 Excellence in AI-Driven Business Transformation by BCC Research for its demonstrated progress in leveraging AI to drive enterprise-wide transformation and measurable business outcomes. During 2025, AT&T continued to expand AI-driven solutions across its core business functions, supported by its proprietary Ask AT&T platform, agentic AI workflows, and an AI-powered network operations suite as part of its broader internal transformation program. Its use of AI-enabled AIOps and real-time predictive analytics enabled network teams to simulate capacity scenarios, identify inefficiencies and potential faults in advance, and enhance the reliability and resilience of its nationwide communications infrastructure.

The award assessment was based on the structured research methodology and process combining market scanning, peer benchmarking, and scoring-based validation across companies implementing AI to drive enterprise-wide business transformation. Evaluation parameters included the strength of internally developed AI capabilities, effectiveness of ecosystem integration, measurable financial impact across business functions, influence on core infrastructure and operations, and the maturity of responsible AI governance and ethical implementation. In accordance with this, AT&T recorded notable results in 2025 through its proprietary Ask AT&T platform, fine-tuned on internal data and scaled to over 100,000 employees, supporting engineering, operations, and customer service functions across the enterprise.

Executive Summary

Braskem has been nominated for the Excellence in New Product Innovation Award in the bio-based polymers sector. The company has shown exceptional performance in the product innovation segment across various fronts, including scientific research, sustainable packaging, patent applications, biodegradability, compostability, and barrier properties. It sets the benchmark for other peers in the bio-based polymers industry on how product innovation can build new business opportunities in the circular economy.

The award assessment was based on the structured research methodology and process combining market scanning, peer benchmarking, and scoring-based validation. Factors such as technological novelty, patent position, application efficiency growth in end use, AI/ML integration, and bio-based content were used to evaluate companies. The analysis was further based on the government publication and availability of public disclosures, sustainability reports of key players, and deployment data of bio-based polymers. In line with this, Braskem focuses on the diverse applications of bio-based Low-density polyethylene (LDPE) and bio-based High-density polyethylene (HDPE) in the global market.

Executive Summary

BCC Research has nominated Danone for the 2025 Excellence in Customer-Centric Innovation Award in the worldwide functional foods and beverage sector. In several important areas, such as digestive health, immunity, early-life nutrition, medical nutrition, high-protein products, and plant-based substitutes, the company has demonstrated a strong capacity to transform evolving consumer health needs into scalable, economically relevant nutrition solutions. With worldwide brands including Activia, Actimel, Aptamil, Alpro, and Nutricia positioned around particular health, and lifestyle needs rather than broad mass-market categories, its innovation methodology is based on a combination of consumer research, nutrition science, and targeted portfolio execution.

Through focused projects, Danone reinforced its customer-centric innovation approach in 2025. With the acquisition of Kate Farms in 2025, the company's specialist nutrition offerings were extended to both everyday consumers and medical channels. On the other hand, the acquisition of the Akkermansia company in 2025 improved its capacity to provide cutting-edge solutions for gut and metabolic health. To accelerate digital science and AI-driven nutrition innovation tailored to local needs, the business also expanded its Singapore Digital Lab in 2025. Danone emerged as one of the strongest nominees because of its close alignment between consumer needs and innovation execution. The award assessment was conducted using an organized methodology that included market scanning, peer benchmarking, and scoring across parameters such as consumer need alignment, insight-driven development, innovation relevance, commercial execution, and growth scalability.

Executive Summary

Deere & Co. is nominated for the 2025 Excellence in Market Impact Award for successfully bridging the gap between advanced digital innovation and observable field results, such as yield improvement of 30% and operational efficiency of 30%-40%. The company adopted high-tech innovations such as 5G technology, artificial intelligence (AI), data analytics, and digital twin into its products, such as See & Spray, to achieve maximum productivity for the farmers. In 2025, Deere & Co. made an impact in the market by transforming traditional farming machinery into a connected and data-driven ecosystem.

The award assessment was based on a structured research methodology combining market scanning, peer benchmarking, and scoring-based validation across companies implementing smart agriculture solutions in real-world farming environments. Evaluation parameters focused on the ability of companies to deliver measurable improvements in operational efficiency and input optimization, develop tailored solutions aligned with specific farmer and crop needs, and adopt sustainable and regenerative farming technologies. In line with this, the company expanded its autonomous AI-driven operations that use the global positioning system (GPS) and light detection and ranging (LIDAR) to enable 24/7 field production, with increased crop yield up to 20% and improved operational excellence by 30%. This technology integration has created a broader market transformation with expansion to over 500 million engaged acres globally.

Executive Summary

Heartflow, Inc. has been nominated for the 2025 Excellence in AI-Driven Business Transformation award by BCC Research for its work in transforming cardiovascular care pathways through AI-based diagnostic technology. This healthcare technology company offers cloud-based, AI-powered solutions for the non-invasive diagnosis and management of coronary artery diseases. As of December 2025, more than 600,000 patients used its platform globally, including 219,000 in 2025 alone, indicating widespread adoption. The company uses AI and computational modeling to create personalized 3D heart models from a single coronary computed tomography angiography (CCTA) scan.

The award assessment used a structured methodology that included market scanning, peer benchmarking, and scoring-based validation, with particular emphasis on AI-driven capital transformation and its role in reshaping the clinical market. In this regard, the company showcased a significant business transformation through a strong IPO performance in August 2025, raising approximately $364 million at a valuation of around $1.54 billion, alongside ~40% revenue growth in FY 2025 primarily generated by its "pay-per-click" model. Further strengthening its clinical impact, the company received FDA clearance in September 2025 for its next-generation AI-powered Plaque Analysis platform.

Executive Summary

Quantinuum is nominated for the 2025 Excellence in Next Generation Technology Award by BCC Research for advancing the application of quantum computing in commercial and industrial operations. During 2025, the company continued to expand its next-generation quantum computing offerings in the pharmaceutical, automotive, financial services, and telecommunications sectors with its Helios quantum computing platform, generative quantum AI framework, and full-stack quantum developer ecosystem as part of its technology offerings. Its commercially available quantum computing and quantum-classical hybrid solutions allowed companies to effectively simulate complex molecules, identify computational bottlenecks not possible with traditional computing, and make mission-critical research and optimization processes more reliable and accurate.

The award assessment was based on a structured research methodology and process combining market scanning, peer benchmarking, and scoring-based validation across companies implementing next-generation quantum technologies in commercial settings. Evaluation parameters included the extent of original scientific innovation and measurable performance improvements against established benchmarks, along with the accessibility of tools and platforms for developer engagement. In accordance with this, the company recorded notable results in 2025 with the commercial deployment of the quantum computing system and quantum volume achievements surpassing the nearest competitor by a factor of 16,000.

Executive Summary

Xylem distinguishes itself as a leader in operational AI for smart water management through its ability to deliver data-driven, performance-oriented water infrastructure solutions at scale. Through its Xylem Vue digital water platform, developed in partnership with Idrica, Xylem enables utilities to integrate real-time data from sensors, SCADA systems, GIS, and operational infrastructure to drive predictive analytics and system-wide operational visibility. By combining deep domain expertise in water infrastructure with cutting-edge analytics, Xylem is transforming conventional systems into intelligent, adaptive networks, driving improvements in efficiency and cost performance globally.

The award assessment follows a structured, evidence-based evaluation framework combining comprehensive market scanning, rigorous shortlisting of smart water technology providers, and detailed organizational analysis. The company's emphasis on broadening its geographic presence strengthens its market strategy and positions it to establish a robust and competitive foothold. Moreover, within this framework, Xylem is evaluated across key dimensions, including AI innovation and technology leadership, measurable operational impact, system reliability, integration with legacy operational technologies, workforce enablement, and financial returns. The assessment incorporates both quantitative performance metrics and qualitative governance indicators to ensure a balanced evaluation.